{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:49:28Z","timestamp":1793317768281,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.rpth.2024.102664","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T17:41:44Z","timestamp":1735062104000},"page":"102664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3806-2250","authenticated-orcid":false,"given":"Nikola","family":"Vladic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9007-7738","authenticated-orcid":false,"given":"Cornelia","family":"Englisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-9717","authenticated-orcid":false,"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7677-9896","authenticated-orcid":false,"given":"Ingrid","family":"Pabinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102664_bib1","article-title":"Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study","volume":"34","author":"S\u00f8rensen","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.rpth.2024.102664_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.rpth.2024.102664_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.thromres.2009.12.023","article-title":"Venous thromboembolism and prognosis in cancer","volume":"125","author":"Khorana","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102664_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2024.07.016","article-title":"Risk of depression after venous thromboembolism in patients with hematological cancer: a population-based cohort study","author":"Steiner","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102664_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102510","article-title":"Quality of life in oncological patients with venous thromboembolic disease","volume":"8","author":"Arteaga","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102664_bib6","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1111\/jth.15902","article-title":"Awareness of venous thromboembolism among patients with cancer: preliminary findings from a global initiative for World Thrombosis Day","volume":"20","author":"Potere","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102664_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024805","article-title":"Long-term psychosocial impact of venous thromboembolism: a qualitative study in the community","volume":"9","author":"Hunter","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.rpth.2024.102664_bib8","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1182\/bloodadvances.2022009577","article-title":"Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study","volume":"7","author":"Crobach","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2024.102664_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12748","article-title":"Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin","volume":"6","author":"Bistervels","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102664_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2021.100080","article-title":"Risk assessment for recurrent venous thromboembolism in patients with cancer","volume":"5","author":"Englisch","year":"2021","journal-title":"Thromb Update"},{"key":"10.1016\/j.rpth.2024.102664_bib11","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1182\/blood.2024025362","article-title":"Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study","volume":"144","author":"Englisch","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102664_bib12","article-title":"Bleeding risk in patients with cancer","author":"Englisch","year":"2024","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.rpth.2024.102664_bib13","first-page":"323","article-title":"Healthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancer","volume":"23","author":"Khorana","year":"2020","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.rpth.2024.102664_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/CEOR.S39964","article-title":"Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States","volume":"5","author":"Khorana","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.rpth.2024.102664_bib15","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1111\/jth.15880","article-title":"Hemostasis and cancer: impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer","volume":"20","author":"Moik","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102664_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1160\/TH16-08-0615","article-title":"Cancer-associated venous thromboembolism: Burden, mechanisms, and management","volume":"117","author":"Ay","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102664_bib17","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102664_bib18","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1200\/JCO.2010.32.8294","article-title":"Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study","volume":"29","author":"Ay","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.rpth.2024.102664_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11739-012-0784-y","article-title":"A\u00a0modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score","volume":"7","author":"Verso","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.rpth.2024.102664_bib20","first-page":"2084","article-title":"[Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?]","volume":"138","author":"Pelzer","year":"2013","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.rpth.2024.102664_bib21","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1200\/JCO.22.01542","article-title":"Derivation and validation of a clinical risk assessment model for cancer-associated thrombosis in two unique US health care systems","volume":"41","author":"Li","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.rpth.2024.102664_bib22","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","article-title":"A\u00a0clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts","volume":"5","author":"Pabinger","year":"2018","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.rpth.2024.102664_bib23","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.3748\/wjg.v27.i19.2325","article-title":"Burden of venous thromboembolism in patients with pancreatic cancer","volume":"27","author":"Frere","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rpth.2024.102664_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10120-023-01378-1","article-title":"Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort","volume":"26","author":"Yoshikawa","year":"2023","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.rpth.2024.102664_bib25","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00432-021-03794-1","article-title":"Predictors for thromboembolism in patients with cholangiocarcinoma","volume":"148","author":"Pfrepper","year":"2022","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.rpth.2024.102664_bib26","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102664_bib27","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3324\/haematol.2012.073338","article-title":"Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study","volume":"98","author":"Dickmann","year":"2013","journal-title":"Haematologica"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2024.102664_bib28","article-title":"A\u00a0new cancer-associated thrombosis risk score improves identification of high-risk patients: external validation in a large population-based cohort study [abstract]","volume":"8","author":"Lanting","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102664_bib29","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","article-title":"A\u00a0predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS\u2013cancer-associated thrombosis study","volume":"22","author":"Gerotziafas","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.rpth.2024.102664_bib30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1634\/theoncologist.2016-0246","article-title":"Preventing venous thromboembolism in ambulatory cancer patients: the ONKOTEV study","volume":"22","author":"Cella","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.rpth.2024.102664_bib31","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41416-018-0027-8","article-title":"Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer","volume":"118","author":"Mu\u00f1oz Mart\u00edn","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.rpth.2024.102664_bib32","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1200\/JCO.22.00255","article-title":"A\u00a0clinical-genetic risk score for predicting cancer-associated venous thromboembolism: a development and validation study involving two independent prospective cohorts","volume":"41","author":"Mu\u00f1oz","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.rpth.2024.102664_bib33","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1634\/theoncologist.2013-0226","article-title":"Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis","volume":"18","author":"Lyman","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.rpth.2024.102664_bib34","article-title":"Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer","volume":"11","author":"Khorana","year":"2023","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.rpth.2024.102664_bib35","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1182\/blood.2020007878","article-title":"Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy","volume":"137","author":"Moik","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102664_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.747075","article-title":"Risk factors, incidence, and prognosis of thromboembolism in cancer patients treated with immune checkpoint inhibitors","volume":"12","author":"Zou","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.rpth.2024.102664_bib37","article-title":"Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer","volume":"11","author":"Drobni","year":"2023","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.rpth.2024.102664_bib38","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/jth.15354","article-title":"Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy","volume":"19","author":"Watson","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102664_bib39","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.21.7752","article-title":"D-dimer and prothrombin fragment 1\u00a0+ 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study","volume":"27","author":"Ay","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.rpth.2024.102664_bib40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10147-024-02475-6","article-title":"Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a cancer-VTE Registry subanalysis","volume":"29","author":"Nakamura","year":"2024","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.rpth.2024.102664_bib41","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood-2008-02-142422","article-title":"High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)","volume":"112","author":"Ay","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102664_bib42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5114\/aoms\/159039","article-title":"Soluble P-selectin level in patients with cancer-associated venous and artery thromboembolism: a systematic review and meta-analysis","volume":"19","author":"Zhang","year":"2023","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.rpth.2024.102664_bib43","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41416-022-01968-3","article-title":"Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications","volume":"127","author":"Koizume","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.rpth.2024.102664_bib44","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1111\/cas.15106","article-title":"Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancer","volume":"112","author":"Kobayashi","year":"2021","journal-title":"Cancer Sci"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2024.102664_bib45","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/blood-2021-154333","article-title":"Thrombin generation as a predictive biomarker for venous thromboembolism in patients with pancreatic and lung cancer undergoing systemic therapy","volume":"138","author":"Emery","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102664_bib46","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rpth.2024.102664_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.910908","article-title":"Impact of neutrophil extracellular traps on thrombosis formation: new findings and future perspective","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.rpth.2024.102664_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/1076029618825310","article-title":"Contact system activation and neutrophil extracellular trap markers: risk factors for portal vein thrombosis in patients with hepatocellular carcinoma","volume":"25","author":"Seo","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102664_bib49","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/jth.14774","article-title":"Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-dimer analysis: a prospective study","volume":"18","author":"Posch","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102664_bib50","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3324\/haematol.2018.209114","article-title":"The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis","volume":"104","author":"Mulder","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102664_bib51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jacasi.2021.07.006","article-title":"Validation of the Khorana venous thromboembolism risk score in Japanese cancer patients","volume":"1","author":"Akasaka-Kihara","year":"2021","journal-title":"JACC Asia"},{"key":"10.1016\/j.rpth.2024.102664_bib52","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","article-title":"Prediction of venous thromboembolism in cancer patients","volume":"116","author":"Ay","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102664_bib53","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3324\/haematol.2017.169060","article-title":"Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study","volume":"102","author":"van Es","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102664_bib54","doi-asserted-by":"crossref","first-page":"e1083","DOI":"10.1634\/theoncologist.2019-0482","article-title":"External validation of a venous thromboembolic risk score for cancer outpatients with solid tumors: the COMPASS-CAT venous thromboembolism risk assessment model","volume":"25","author":"Spyropoulos","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.rpth.2024.102664_bib55","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/jth.15503","article-title":"Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer","volume":"19","author":"Guman","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102664_bib56","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1055\/s-0044-1785482","article-title":"Machine learning as a diagnostic and prognostic tool for predicting thrombosis in cancer patients: a systematic review","volume":"50","author":"El-Sherbini","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102664_bib57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jocm.2018.07.002","article-title":"Is your dataset big enough? Sample size requirements when using artificial neural networks for discrete choice analysis","volume":"28","author":"Alwosheel","year":"2018","journal-title":"J\u00a0Choice Model"},{"key":"10.1016\/j.rpth.2024.102664_bib58","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ajh.24700","article-title":"Predicting risk of venous thromboembolism in hospitalized cancer patients: utility of a risk assessment tool","volume":"92","author":"Patell","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2024.102664_bib59","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.54352","article-title":"Risk of venous thromboembolic events after surgery for cancer","volume":"7","author":"Bj\u00f6rklund","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.rpth.2024.102664_bib60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2024.102664_bib61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation","volume":"83","author":"Joglar","year":"2024","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl 3","key":"10.1016\/j.rpth.2024.102664_bib62","first-page":"304","article-title":"Clinical assessment of venous thromboembolic risk in surgical patients","volume":"17","author":"Caprini","year":"1991","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102664_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpsurg.2022.101221","article-title":"Thrombosis prophylaxis in surgical patients using the Caprini Risk Score","volume":"59","author":"Wilson","year":"2022","journal-title":"Curr Probl Surg"},{"key":"10.1016\/j.rpth.2024.102664_bib64","first-page":"267","article-title":"Thromboembolism in gastrointestinal cancers","volume":"2","author":"Tetzlaff","year":"2008","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.rpth.2024.102664_bib65","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1212\/WNL.0000000000011414","article-title":"Risk of venous thromboembolism in grade II\u2013IV gliomas as a function of molecular subtype","volume":"96","author":"Diaz","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.rpth.2024.102664_bib66","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.rpth.2024.102664_bib67","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO clinical practice guideline","volume":"34","author":"Falanga","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rpth.2024.102664_bib68","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2024.102664_bib69","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjh.19414","article-title":"Cancer-associated venous thrombosis in adults (second edition): a British Society for Haematology guideline","volume":"205","author":"Alikhan","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102664_bib70","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.rpth.2024.102664_bib71","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to prevent venous thromboembolism in patients with cancer","volume":"380","author":"Carrier","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102664_bib72","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa1814630","article-title":"Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer","volume":"380","author":"Khorana","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102664_bib73","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1182\/bloodadvances.2020003115","article-title":"Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis","volume":"4","author":"Bosch","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2024.102664_bib74","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/onco.13540","article-title":"D-dimer enhances risk-targeted thromboprophylaxis in ambulatory patients with cancer","volume":"25","author":"Kumar","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.rpth.2024.102664_bib75","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/jamaoncol.2023.3634","article-title":"Risk-directed ambulatory thromboprophylaxis in lung and gastrointestinal cancers: the TARGET-TP randomized clinical trial","volume":"9","author":"Alexander","year":"2023","journal-title":"JAMA Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2024.102664_bib76","article-title":"Risk of CAR T-cell therapy-related thrombosis and bleeding: preliminary results of the multicenter \u2018Follow that CAR\u2019 registry [abstract]","volume":"8","author":"Ko","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2024.102664_bib77","article-title":"Low-molecular-weight heparin for the prevention of venous thromboembolism in adults with newly diagnosed acute lymphoblastic leukemia; prospective side-study of the HOVON-100 trial [abstract]","volume":"8","author":"Lauw","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2024.102664_bib78","article-title":"Risk of early venous thromboembolism in patients with acute leukemia [abstract]","volume":"8","author":"Bansal","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2024.102664_bib79","article-title":"Performance of established risk assessment models for the prediction of VTE in patients with cancer receiving systemic anti-cancer therapies \u2013 results from a contemporary perspective cohort study [abstract]","volume":"8","author":"Vladic","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2024.102664_bib80","article-title":"The Vienna CATScore for predicting VTE risk in patients with cancer: an external validation across multiple time-points [abstract]","volume":"8","author":"Englisch","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102664_bib81","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920907540","article-title":"Efficacy and safety of thromboprophylaxis in cancer patients: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.rpth.2024.102664_bib82","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.3390\/cancers13122884","article-title":"The impact of thromboprophylaxis on the survival of patients with advanced pancreatic cancer. The pancreatic cancer and tinzaparin (PaCT) study","volume":"13","author":"Karamouzis","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.rpth.2024.102664_bib83","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2023-187867","article-title":"Risks for venous thromboembolism with immune checkpoint inhibitor therapy","volume":"142","author":"Connors","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102664_bib84","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jtha.2024.03.021","article-title":"A\u00a0meta-analysis to assess the risk of bleeding and thrombosis following chimeric antigen receptor T-cell therapy: communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy","volume":"22","author":"Bindal","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2024.102664_bib85","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1182\/blood-2023-180203","article-title":"Venous thromboembolism (VTE) in post-CAR-T patients - a meta-analysis of phase 2 & 3 clinical trials","volume":"142","author":"Chitkara","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102664_bib86","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood-2015-01-625582","article-title":"When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data","volume":"127","author":"Walker","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102664_bib87","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1182\/bloodadvances.2021006623","article-title":"Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort","volume":"6","author":"Blondon","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2024.102664_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109087","article-title":"Venous thromboembolism in women with hormone-dependent breast cancer. To continue or discontinue hormonal treatment? Insights from the RIETE registry","volume":"241","author":"P\u00e9rez-Jacoiste As\u00edn","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102664_bib89","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/ATVBAHA.120.314378","article-title":"Cancer therapy-associated thrombosis","volume":"41","author":"Grover","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2024.102664_bib90","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.2008.656","article-title":"Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis","volume":"300","author":"Nalluri","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2024.102664_bib91","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/jnci\/djm086","article-title":"Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab","volume":"99","author":"Scappaticci","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.rpth.2024.102664_bib92","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/d41573-024-00064-w","article-title":"The antibody\u2013drug conjugate landscape","volume":"23","author":"Flynn","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.rpth.2024.102664_bib93","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ajh.25494","article-title":"Bleeding incidence and risk factors among cancer patients treated with anticoagulation","volume":"94","author":"Angelini","year":"2019","journal-title":"Am J Hematol"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2024.102664_bib94","article-title":"Growth differentiation factor-15 is associated with risk of major bleeding in patients with cancer: results from a prospective cohort study [abstract]","volume":"8","author":"Englisch","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102664_bib95","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.blre.2018.06.002","article-title":"Venous thromboembolism incidence in hematologic malignancies","volume":"33","author":"Kekre","year":"2019","journal-title":"Blood Rev"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924003595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924003595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T23:51:14Z","timestamp":1751932274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924003595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2475037924003595"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102664","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102664"}}